Vanguard to purchase Arizona Heart Institute

Kaitlyn Dmyterko | | Health Imaging | Enterprise Imaging
Under a definitive purchasing agreement, Phoenix-based Abrazo Health Care, a subsidiary of Vanguard Health Systems, will purchase the Arizona Heart Institute (AHI), an independent cardiovascular physician practice.

While the financial terms of the agreement remain undisclosed, the Nashville, Tenn.-based Vanguard said the deal will take place under a section 363 sale and is part of its reorganization plan to expand its cardiovascular network of community-based physicians.

The addition of AHI will add to Abrazo's portfolio that currently includes five hospitals including Arrowhead Hospital, Maryvale Hospital, Paradise Valley Hospital, Phoenix Baptist Hospital, and West Valley Hospital—all located in Phoenix.

According to Vanguard, the deal will be subject to the approval of the court.

Kaitlyn Dmyterko

Related Content

Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms
AI-based software improves follow-up imaging adherence by 74%

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.